Study Designs and Statistical Analyses for Biomarker Research

被引:52
|
作者
Gosho, Masahiko [1 ]
Nagashima, Kengo [1 ,2 ]
Sato, Yasunori [3 ]
机构
[1] Tokyo Univ Sci, Grad Sch Engn, Shinjuku Ku, Tokyo 1628601, Japan
[2] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan
[3] Chiba Univ Med, Clin Res Ctr, Chuo Ku, Chiba 2608677, Japan
来源
SENSORS | 2012年 / 12卷 / 07期
基金
日本学术振兴会;
关键词
biomarker adaptive design; confounding; multiplicity; predictive factor; statistical test; CLINICAL-TRIAL DESIGNS; FALSE DISCOVERY RATE; SURROGATE ENDPOINTS; GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; VALIDATION; POLYMORPHISMS; CHEMOTHERAPY; PROGNOSIS;
D O I
10.3390/s120708966
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Biomarkers are becoming increasingly important for streamlining drug discovery and development. In addition, biomarkers are widely expected to be used as a tool for disease diagnosis, personalized medication, and surrogate endpoints in clinical research. In this paper, we highlight several important aspects related to study design and statistical analysis for clinical research incorporating biomarkers. We describe the typical and current study designs for exploring, detecting, and utilizing biomarkers. Furthermore, we introduce statistical issues such as confounding and multiplicity for statistical tests in biomarker research.
引用
收藏
页码:8966 / 8986
页数:21
相关论文
共 50 条
  • [31] AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses
    Liu, Mingjian
    Yu, Yuyu
    Zhang, Ziqian
    Chen, Zhenghong
    Chen, Bin
    Cheng, Yijun
    Wei, Yongxu
    Li, Jia
    Shang, Hanbing
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (22)
  • [32] Ceramic investigation: how to perform statistical analyses
    Papageorgiou, Ioulia
    ARCHAEOLOGICAL AND ANTHROPOLOGICAL SCIENCES, 2020, 12 (09)
  • [33] Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study
    Lee, Ji Hyun
    Lee, Ho Yun
    Ahn, Myung-Ju
    Park, Keunchil
    Ahn, Jin Seok
    Sun, Jong-Mu
    Lee, Kyung Soo
    CANCER IMAGING, 2016, 16
  • [34] Levels of evidence and study designs: A brief introduction to dermato-epidemiologic research methodology
    Chen, Yen-Ning
    Chi, Ching-Chi
    DERMATOLOGICA SINICA, 2023, 41 (04) : 199 - 205
  • [35] Do longitudinal orthodontic trials use appropriate statistical analyses? A meta-epidemiological study
    Mheissen, Samer
    Khan, Haris
    Almuzian, Mohammed
    Alzoubi, Emad Eddin
    Pandis, Nikolaos
    EUROPEAN JOURNAL OF ORTHODONTICS, 2022, 44 (03) : 352 - 357
  • [36] Statistical designs for two-color spotted microarray experiments
    Chai, Feng-Shun
    Liao, Chen-Tuo
    Tsai, Shin-Fu
    BIOMETRICAL JOURNAL, 2007, 49 (02) : 259 - 271
  • [37] Contextualizing Statistical Suppression Within Pretest-Posttest Designs
    Farmus, Linda
    Weiss, Jonathan A.
    Tajik-Parvinchi, Diana
    Cribbie, Robert A.
    QUANTITATIVE METHODS FOR PSYCHOLOGY, 2020, 16 (01): : 21 - 32
  • [38] Gerontologic Biostatistics: The Statistical Challenges of Clinical Research with Older Study Participants
    Van Ness, Peter H.
    Charpentier, Peter A.
    Ip, Edward H.
    Leng, Xiaoyan
    Murphy, Terrence E.
    Tooze, Janet A.
    Allore, Heather G.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (07) : 1386 - 1392
  • [39] Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
    Chen, Yanru
    Wang, Wei
    Fang, Lingyu
    Zhang, Zhenyang
    Deng, Shishan
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [40] BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
    E S Papadakis
    T Reeves
    N H Robson
    T Maishman
    G Packham
    R I Cutress
    British Journal of Cancer, 2017, 116 : 1585 - 1594